Effects of Inhaled Ketamine on Asthma in Rats
Author Information
Author(s): Zhu Min Min, Zhou Qin Hai, Zhu Mei Hua, Bo Rong Hai, Xu Yu Ming, Qian Yan Ning, Fu Cheng Zhang
Primary Institution: Nanjing Medical University
Hypothesis
Can inhaled ketamine effectively reduce airway hyperresponsiveness and inflammation in a rat model of allergic asthma?
Conclusion
Inhalation of nebulized ketamine significantly reduced airway hyperresponsiveness and inflammation in a rat model of allergic asthma.
Supporting Evidence
- Ketamine inhalation significantly decreased airway reactivity to acetylcholine.
- Inflammatory markers in bronchoalveolar lavage fluid were reduced after ketamine treatment.
- Ketamine treatment led to lower levels of interleukin-4 in the lungs of treated rats.
- Histological examination showed reduced inflammatory cell infiltration in lung tissues.
Takeaway
This study found that giving ketamine through a mist can help reduce asthma symptoms in rats, making it a potential new treatment for asthma.
Methodology
Brown-Norway rats were sensitized with ovalbumin and treated with nebulized ketamine or saline, followed by assessment of airway responsiveness and inflammation markers.
Limitations
The study was conducted on rats, and results may not directly translate to humans.
Participant Demographics
Male Brown-Norway rats, aged 7-11 weeks, weighing 130-170 g.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website